Synthesis and Antibacterial Activity of Bis-[1-(Adamantan-1-Yl)Ethyl]Amine Hydrochloride
- Authors: Krylov V.I.1, Moiseev S.V.1, Kutin A.A.1, Sakhno N.G.1, Gunar O.V.1, Yashkir V.A.1, Merkulov V.A.1
- 
							Affiliations: 
							- Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
 
- Issue: Vol 49, No 12 (2016)
- Pages: 821-824
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244300
- DOI: https://doi.org/10.1007/s11094-016-1379-0
- ID: 244300
Cite item
Abstract
An impurity in rimantadine hydrochloride drug substance that was previously undescribed in regulatory documents and the literature was identified. Its structure was elucidated and confirmed by a convergent synthesis. A method for synthesizing bis-[1-(adamantan-1-yl)ethyl]amine hydrochloride under laboratory conditions was developed. The antibacterial activity of the synthesized compound was assessed.
About the authors
V. I. Krylov
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: MoissevSV@expmed.ru
				                					                																			                												                	Russian Federation, 							Moscow, 127051						
S. V. Moiseev
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
							Author for correspondence.
							Email: MoissevSV@expmed.ru
				                					                																			                												                	Russian Federation, 							Moscow, 127051						
A. A. Kutin
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: MoissevSV@expmed.ru
				                					                																			                												                	Russian Federation, 							Moscow, 127051						
N. G. Sakhno
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: MoissevSV@expmed.ru
				                					                																			                												                	Russian Federation, 							Moscow, 127051						
O. V. Gunar
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: MoissevSV@expmed.ru
				                					                																			                												                	Russian Federation, 							Moscow, 127051						
V. A. Yashkir
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: MoissevSV@expmed.ru
				                					                																			                												                	Russian Federation, 							Moscow, 127051						
V. A. Merkulov
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation
														Email: MoissevSV@expmed.ru
				                					                																			                												                	Russian Federation, 							Moscow, 127051						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					